当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第18期
编号:185882
噻托溴铵吸入剂在慢阻肺患者中的应用效果及对气道阻力的影响研究
http://www.100md.com 2021年3月27日 中国医学创新 2021年第18期
肺功能,慢性阻塞性肺疾病
     丁巍巍

    【关键词】 噻托溴铵 慢性阻塞性肺疾病 气道阻力 肺功能 T细胞亚群

    [Abstract] Objective: To investigate the clinical effect of Tiotropium Bromide inhalation adjuvant therapy in patients with chronic obstructive pulmonary disease (COPD) and its effect on airway resistance. Method: A total of 134 COPD patients admitted to our hospital from February 2018 to January 2021 were selected as the study subjects. The patients were divided into control group and observation group by random drawing, 67 cases in each group. Patients in the control group were given Doxotheophylline Injection on the basis of conventional treatment, and the observation group was given Tiotropium Bromide Inhaled Powder Aerosol on the basis of the control group, both groups were given continuous medication for 2 weeks. Clinical efficacy, lung function indexes, changes in peripheral blood T lymphocyte subsets, airway resistance and the incidence of adverse reactions in two groups were compared. Result: After 2 weeks of treatment, the total effective rate of the observation group was 91.04% ......

您现在查看是摘要页,全文长 12034 字符